At DiMe’s Healthcare 2030 Summit, four healthcare leaders shared the innovations they believe could most improve care, from AI-driven solutions to reduce medical errors to stronger primary care relationships that could save billions. The post 4 Execs’ Wishes for a Better Healthcare Future appeared first on MedCity News.
Say you live in deep-red Louisiana, a state that has effectively banned abortion. It may be easier for you to get abortion pills now than before the Supreme Court overturned Roe v. Wade. Here’s why — and what it means for future battles over abortion access. And as a federal court mulls a case that…
The bill clarifies very specific patient protections and codifies a Patient’s Bill of Rights, all of which would ensure that individuals receiving supplemental oxygen in the home – and their suppliers – understand requirements around equipment, communications, and care options. The post SOAR Act Would Help Individuals Relying on Oxygen Thrive appeared first on MedCity…
Boston-based startup Cascala Health raised an $8.6 million seed round to expand its AI platform for risk-bearing providers. The platform is designed to make patient care transitions safer and more efficient, as well as to help care teams spot risks earlier. The post AI Meets Care Transitions: How One Startup Is Seeking to Reduce Readmissions…
The Phase 3 results in China are encouraging for Kailera Therapeutics, which holds rights to the molecule in the rest of the world. The startup is preparing a global clinical development program for this drug, a once-weekly injectable GLP-1 and GIP receptor agonist. The post Hengrui Pharma’s Potential Rival to El Lilly’s Zepbound Leads to…
By reimagining clinical trials as the initial step in designing a service ecosystem, organizations can accelerate time to delivery and lay the groundwork for successful commercialization. The post Building Service Infrastructure for “Made-To-Order” Therapies appeared first on MedCity News.
The European Union’s highest court sided with Illumina, agreeing that the European Commission had no authority to review the acquisition of liquid biopsy company Grail. The ruling comes after Illumina stopped challenging antitrust litigation, opting to instead spin out Grail as a standalone company. The post Illumina’s European Court Victory Can’t Salvage Grail Acquisition, But…
Jennifer Noonan of Accessia Health explains why ending Medicare Part D subsidies could increase coverage losses, strain nonprofit assistance programs, and make navigating Medicare even more challenging for vulnerable patients
Amye Joseph says America’s political polarization has made it an “interesting time” in her Tennessee household. She and her husband, Charlie, have been married 35 years. She’s a Republican. He’s a Democrat. But their shared disenchantment with profit-driven healthcare has provided a unifying target: pharmacy benefit managers, known as PBMs. The Josephs’ frustration is focused…